Jan. 30, 2024, 2:51 p.m. | Hayley Cuccinello (hcuccinello@businessinsider.com)

Business Insider www.businessinsider.com

The wealthy are betting on 3D printed organs, AI-fueled drug discovery, and longevity VC funds. The biggest hurdle: telling the scientists from snake oil salesmen.

bi-illustration biotech discovery drug discovery finance health healthcare investing longevity oil scientists snake tech tyler le wealthy

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US